Literature DB >> 16304191

VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid.

Spyros Pournaras1, Alexandros Ikonomidis, Leonidas S Tzouvelekis, Despoina Tokatlidou, Nicholas Spanakis, Antonios N Maniatis, Nicholas J Legakis, Athanassios Tsakris.   

Abstract

A transferable plasmid from Klebsiella pneumoniae carried a class 1 integron containing bla(VIM-12), a novel bla(VIM)-type gene, flanked by two copies of aacA7. bla(VIM-12) was clustered between bla(VIM-1) and bla(VIM-2) and differed from bla(VIM-1) by 18 nucleotides that were all located at the 3' end and matched the corresponding nucleotides in bla(VIM-2). The bla(VIM-12)-associated 59-base element was identical to that described in bla(VIM-2) alleles.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16304191      PMCID： PMC1315972          DOI： 10.1128/AAC.49.12.5153-5156.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Standard numbering scheme for class B beta-lactamases.

Authors:  M Galleni; J Lamotte-Brasseur; G M Rossolini; J Spencer; O Dideberg; J M Frère
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

3.  Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece.

Authors:  A Mavroidi; A Tsakris; E Tzelepi; S Pournaras; V Loukova; L S Tzouvelekis
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

Review 4.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

5.  Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

Authors:  P L Winokur; A Brueggemann; D L DeSalvo; L Hoffmann; M D Apley; E K Uhlenhopp; M A Pfaller; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes.

Authors:  L Poirel; T Lambert; S Türkoglü; E Ronco; J Gaillard; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

7.  In70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette.

Authors:  M L Riccio; L Pallecchi; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme.

Authors:  J J Yan; P R Hsueh; W C Ko; K T Luh; S H Tsai; H M Wu; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

9.  Molecular heterogeneity of bla(VIM-2)-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase.

Authors:  L Pallecchi; M L Riccio; J D Docquier; R Fontana; G M Rossolini
Journal:  FEMS Microbiol Lett       Date:  2001-02-20       Impact factor: 2.742

10.  PCR mapping of integrons reveals several novel combinations of resistance genes.

Authors:  C Lévesque; L Piché; C Larose; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191
View more
  15 in total

1.  Systematic analysis of metallo-β-lactamases using an automated database.

Authors:  Michael Widmann; Jürgen Pleiss; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

2.  Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.

Authors:  Costas C Papagiannitsis; Simona Pollini; Filomena De Luca; Gian Maria Rossolini; Jean-Denis Docquier; Jaroslav Hrabák
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

Review 3.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital.

Authors:  Sonia Ktari; Guillaume Arlet; Basma Mnif; Valérie Gautier; Fouzia Mahjoubi; Mounir Ben Jmeaa; Mounir Bouaziz; Adnane Hammami
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

5.  First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.

Authors:  Alexandros Ikonomidis; Maria Labrou; Zoe Afkou; Antonios N Maniatis; Danai Sofianou; Athanassios Tsakris; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

6.  Emergence of VIM-12 in Enterobacter cloacae.

Authors:  Maria Panopoulou; Eleonora Alepopoulou; Alexandros Ikonomidis; Anastasia Grapsa; Eleni Paspalidou; Sofia Kartali-Ktenidou
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

7.  Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital.

Authors:  Despina Tokatlidou; Maria Tsivitanidou; Spyros Pournaras; Alexandros Ikonomidis; Athanassios Tsakris; Danae Sofianou
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

8.  Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.

Authors:  Carlos Juan; Alejandro Beceiro; Olivia Gutiérrez; Sebastián Albertí; Margalida Garau; José L Pérez; Germán Bou; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

9.  Relative strengths of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active p2 promoter.

Authors:  Costas C Papagiannitsis; Leonidas S Tzouvelekis; Vivi Miriagou
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

Review 10.  Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.

Authors:  Guillermo Bahr; Lisandro J González; Alejandro J Vila
Journal:  Chem Rev       Date:  2021-06-15       Impact factor: 72.087
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.